Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT) (ABSORB CHINA)

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Abbott Vascular Identifier:
First received: July 25, 2013
Last updated: August 26, 2016
Last verified: August 2016